Twin Tree Management
TEVA icon

Twin Tree Management’s Teva Pharmaceuticals TEVA Stock Holding History

Twin Tree Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400
Closed -$3.65K – 1577
2022
Q4 		$3.65K Sell
400
-352,900
-100% -$3.08M ﹤0.01% 1231
2022
Q3 		$2.85M Buy
+353,300
New +$3.12M 0.01% 882
2021
Q1 		– Sell
-210,800
Closed -$2.03M – 1602
2020
Q4 		$2.03M Sell
210,800
-6,000
-3% -$57.5K 0.01% 849
2020
Q3 		$1.95M Sell
216,800
-1,407,800
-87% -$14.9M 0.01% 771
2020
Q2 		$20M Sell
1,624,600
-261,400
-14% -$2.96M 0.08% 277
2020
Q1 		$16.9M Buy
1,886,000
+1,805,000
+2,228% +$18.5M 0.08% 217
2019
Q4 		$794K Buy
+81,000
New +$723K ﹤0.01% 897
2019
Q3 		– Sell
-601,000
Closed -$5.55M – 1515
2019
Q2 		$5.55M Sell
601,000
-1,155,300
-66% -$13.9M 0.03% 435
2019
Q1 		$27.5M Sell
1,756,300
-43,700
-2% -$771K 0.14% 125
2018
Q4 		$27.8M Buy
1,800,000
+1,224,600
+213% +$25.1M 0.17% 102
2018
Q3 		$12.4M Sell
575,400
-910,300
-61% -$21.1M 0.08% 208
2018
Q2 		$36.1M Buy
1,485,700
+480,100
+48% +$9.79M 0.22% 84
2018
Q1 		$17.2M Buy
1,005,600
+317,600
+46% +$6.2M 0.14% 123
2017
Q4 		$13M Buy
+688,000
New +$10.3M 0.1% 179
2017
Q3 		– Sell
-91,800
Closed -$3.05M – 1157
2017
Q2 		$3.05M Sell
91,800
-885,900
-91% -$27.4M 0.02% 478
2017
Q1 		$31.4M Buy
977,700
+762,400
+354% +$26M 0.28% 67
2016
Q4 		$7.8M Buy
215,300
+199,200
+1,237% +$7.95M 0.08% 296
2016
Q3 		$741K Sell
16,100
-25,600
-61% -$1.34M 0.01% 745
2016
Q2 		$2.1M Sell
41,700
-44,800
-52% -$2.38M 0.03% 475
2016
Q1 		$4.63M Sell
86,500
-92,600
-52% -$5.43M 0.09% 234
2015
Q4 		$11.8M Buy
179,100
+119,900
+203% +$7.41M 0.23% 74
2015
Q3 		$3.34M Sell
59,200
-10,100
-15% -$655K 0.09% 223
2015
Q2 		$4.1M Sell
69,300
-36,400
-34% -$2.25M 0.1% 205
2015
Q1 		$6.58M Buy
105,700
+8,600
+9% +$500K 0.17% 123
2014
Q4 		$5.58M Sell
97,100
-59,300
-38% -$3.3M 0.16% 130
2014
Q3 		$8.41M Buy
156,400
+25,400
+19% +$1.35M 0.22% 76
2014
Q2 		$6.87M Sell
131,000
-135,800
-51% -$6.94M 0.15% 133
2014
Q1 		$14.1M Buy
266,800
+118,200
+80% +$5.46M 0.29% 35
2013
Q4 		$5.96M Buy
148,600
+126,000
+558% +$4.96M 0.14% 136
2013
Q3 		$854K Sell
22,600
-36,600
-62% -$1.43M 0.03% 506
2013
Q2 		$2.32M Buy
+59,200
New +$2.31M 0.09% 270

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Twin Tree Management's TEVA Position: Q2 2023 in Review

Twin Tree Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 2,141 shares — an estimated $18.9K sold.

Twin Tree Management first reported a position in TEVA in Q2 2013 and held it in 31 quarters. The position peaked at $11.4M in Q1 2017. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • Twin Tree Management reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Twin Tree Management sold 2,141 Teva Pharmaceuticals shares in Q2 2023, an estimated $18.9K.
  • Twin Tree Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • Twin Tree Management's Teva Pharmaceuticals position peaked at $11.4M in Q1 2017.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Twin Tree Management's 13F filing for Q2 2023, filed 11 Aug 2023.